Last updated on March 2019

Safety Tolerability Pharmacokinetics and Efficacy of LMB763 in Patients With NASH


Brief description of study

The purpose of the present study is to assess the effects of LMB763 with respect to safety, tolerability, and on markers of liver inflammation in patients with NASH

Clinical Study Identifier: NCT02913105

Contact Investigators or Research Sites near you

Start Over

Novartis Investigative Site

Miami Springs, FL United States

Novartis Investigative Site

Orlando, FL United States

Novartis Investigative Site

Baton Rouge, LA United States

Novartis Investigative Site

Nedlands, Australia

Novartis Investigative Site

Tbilisi, Georgia

Novartis Investigative Site

San Juan, Puerto Rico

Novartis Investigative Site

Bern, Switzerland

Novartis Investigative Site

Lugano, Switzerland

Novartis Investigative Site

Headington, United Kingdom

Novartis Investigative Site

Glasgow, United Kingdom

Novartis Investigative Site

Geneve 14, Switzerland

Novartis Investigative Site

Boston, MA United States

Novartis Investigative Site

High Point, NC United States

Novartis Investigative Site

Houston, TX United States

Novartis Investigative Site

Papatoetoe, New Zealand

Novartis Investigative Site

Llantrisant, United Kingdom

Novartis Investigative Site

London, United Kingdom

Novartis Investigative Site

St Gallen, Switzerland

Novartis Investigative Site

Culver City, CA United States

Novartis Investigative Site

Cypress, CA United States

Novartis Investigative Site

Gainesville, FL United States

Novartis Investigative Site

Honolulu, HI United States

Novartis Investigative Site

Nashville, TN United States

Novartis Investigative Site

Arlington, TX United States

Novartis Investigative Site

Newport News, VA United States

Novartis Investigative Site

New Lambton, Australia

Novartis Investigative Site

Auckland, New Zealand

Novartis Investigative Site

Christchurch, New Zealand

Novartis Investigative Site

Tauranga, New Zealand

Novartis Investigative Site

Wellington, New Zealand

Novartis Investigative Site

Plymouth, United Kingdom

Novartis Investigative Site

Portsmouth, United Kingdom

Recruitment Status: Closed


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.